Page 2 - Vulvar Cancer Guidelines Summary fxd

The European Society of Gynaecological Oncology (ESGO) developed guidelines covering
diagnosis and referral, preoperative investigations, surgical management (local
treatment, groin treatment, reconstructive surgery), sentinel lymph node procedure,
radiation therapy, chemoradiation, systemic reatment, treatment of recurrent disease
(vulvar recurrence, groin recurrence, distant metastases), and follow-up for patients
with vulvar cancer.

A five-step development process was followed:
Nomination of multidisciplinary international development group

Identification of scientific evidence

Formulation of recommendations

External evaluation of guidelines (international review)

Integration of international reviewers comments

The objectives of these guidelines are to improve and to homogenize the management of
patients with vulvar cancer. The guidelines are intended for use by gynaecological
oncologists, general gynaecologists, surgeons, pathologists, radiotherapists, medical and
clinical oncologists, general practitioners, palliative care teams, and allied health
professionals.
These guidelines apply to adults over the age of 18 years with squamous cell carcinoma
of the vulva. These guidelines do not address patients with other vulvar cancer
histologies. Any clinician seeking to apply or consult these guidelines is expected to use
independent medical judgment in the context of individual clinical circumstances to
determine any patient’s care or treatment.

2  VULVAR CANCER - GUIDELINES 